 Biocept Inc NASDAQ:BIOC announced that coronavirus COVID-19 RT-PCR testing volume has increased in 2022 with the emergence of the Omicron variant. The San Diego-based company said that it continues to serve the community with high-quality testing, having received more than 40,000 samples for COVID-19 testing since the beginning of 2022 and more than 765,000 samples since initiating this service in June 2020. 